PIEZO-ICSI increases fertilization rates compared with conventional ICSI in patients with poor prognosis
- PMID: 36586007
- PMCID: PMC9935778
- DOI: 10.1007/s10815-022-02701-y
PIEZO-ICSI increases fertilization rates compared with conventional ICSI in patients with poor prognosis
Abstract
Purpose: Limited research has been published comparing PIEZO-ICSI with conventional ICSI. While positive effects have been documented in improving fertilization and degeneration, the outcomes in patients with previous poor results from conventional ICSI remain unclear. It is hypothesized that these patients may benefit the most from this form of insemination.
Methods: This retrospective paired within-patient cohort study investigated patients (n=72) undertaking PIEZO-ICSI after a previous conventional ICSI cycle resulted in poor outcomes (including low fertilization (<50%), high degeneration (>15%), and/or poor embryo development and utilization). Patients required at least five oocytes collected in both cycles and a period of less than 2 years between the cycles. The outcomes of both cycles were compared in respect to fertilization, degeneration, embryo utilization, and pregnancy rates. Further analyses were applied to patients <38 and ≥38 years of age, with <50% or ≥50% fertilization with conventional ICSI and with <20% or ≥20% utilization with conventional ICSI.
Results: PIEZO-ICSI resulted in significantly higher fertilization (61.9% vs 45.3%, P<0.0001) and lower degeneration (7.7% vs 18.2%, P=0.0001) when compared to the conventional ICSI cycles. The greatest benefit was seen in patients who had less than 50% fertilization or <20% utilization in their conventional ICSI cycle, with improvements in fertilization and degeneration rates resulting in a significantly higher number of embryos utilized (frozen or transferred) per cycle.
Conclusions: PIEZO-ICSI improved fertilization, degeneration, and utilization rates in patients with previous poor outcomes from conventional ICSI. The number of embryos available for use per cycle was also increased. Further significant improvements were achieved in patients who exhibited poor fertilization (<50%) or low utilization (<20%) from conventional ICSI.
Keywords: Advanced maternal age; Degeneration; Fertilization; ICSI; PIEZO.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
PIEZO-ICSI increases fertilization rates compared with standard ICSI: a prospective cohort study.Reprod Biomed Online. 2021 Sep;43(3):404-412. doi: 10.1016/j.rbmo.2021.05.020. Epub 2021 May 31. Reprod Biomed Online. 2021. PMID: 34326006 Clinical Trial.
-
The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.Hum Reprod. 2017 Jan;32(1):119-124. doi: 10.1093/humrep/dew298. Epub 2016 Nov 16. Hum Reprod. 2017. PMID: 27852688
-
Day after rescue ICSI: eliminating total fertilization failure after conventional IVF with high live birth rates following cryopreserved blastocyst transfer.Hum Reprod. 2023 Jul 5;38(7):1277-1283. doi: 10.1093/humrep/dead097. Hum Reprod. 2023. PMID: 37208859
-
Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.Front Endocrinol (Lausanne). 2020 Jul 17;11:427. doi: 10.3389/fendo.2020.00427. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32765424 Free PMC article.
-
Should rescue ICSI be re-evaluated considering the deferred transfer of cryopreserved embryos in in-vitro fertilization cycles? A systematic review and meta-analysis.Reprod Biol Endocrinol. 2021 Aug 4;19(1):121. doi: 10.1186/s12958-021-00784-3. Reprod Biol Endocrinol. 2021. PMID: 34348713 Free PMC article.
Cited by
-
Human metaphase II oocytes with narrow perivitelline space have poor fertilization, developmental, and pregnancy potentials.J Assist Reprod Genet. 2024 May;41(5):1449-1458. doi: 10.1007/s10815-024-03084-y. Epub 2024 Mar 19. J Assist Reprod Genet. 2024. PMID: 38499932 Free PMC article.
-
Assisted sperm fusion insemination improves fertilization rates and increases usable embryos for transfer: a clinical sibling-oocyte study.F S Rep. 2024 Nov 23;6(1):17-24. doi: 10.1016/j.xfre.2024.11.006. eCollection 2025 Mar. F S Rep. 2024. PMID: 40201099 Free PMC article.
-
A micro-fabricated device (microICSI) improves porcine blastocyst development and procedural efficiency for both porcine intracytoplasmic sperm injection and human microinjection.J Assist Reprod Genet. 2024 Feb;41(2):297-309. doi: 10.1007/s10815-023-03018-0. Epub 2024 Jan 18. J Assist Reprod Genet. 2024. PMID: 38236552 Free PMC article.
-
Comparison of the clinical outcomes between conventional intracytoplasmic sperm injection (ICSI) and PIEZO-ICSI in women undergoing the first cycle of in-vitro fertilization.PLoS One. 2025 Aug 29;20(8):e0330951. doi: 10.1371/journal.pone.0330951. eCollection 2025. PLoS One. 2025. PMID: 40880358 Free PMC article. Clinical Trial.
-
The Pre-Catching Sperm Technique Increases the Efficiency of the Intracytoplasmic Sperm Injection Method by Improving Fertilization and Blastocyst Formation Rates.J Clin Med. 2025 Jul 9;14(14):4872. doi: 10.3390/jcm14144872. J Clin Med. 2025. PMID: 40725562 Free PMC article.
References
-
- European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Wyns C, De Geyter C, Calhaz-Jorge C, Kupka MS, Motrenko T, Smeenk J, Bergh C, Tandler-Schneider A, Rugescu IA, Vidakovic S, Goossens V. ART in Europe, 2017: results generated from European registries by ESHRE. Hum Reprod Open. 2021;2021(3). 10.1093/hropen/hoab026. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources